Ablative Radiotherapy in Metastatic Disease Registry

Purpose of this Study

We are doing this study to collect information about people with oligometastasis for future use.

Who Can Participate?

Eligibility

Adults who:<ul>
<li>Have cancer that has spread to other parts of the body</li>
<li>Planning to undergo ablative radiotherapy</li></ul>

Age Range

18-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

If you decide to join this study you will come in for one visit to let us collect data about you, your disease, and your treatment.

Locations

Remote/online

Compensation

No

Spanish Materials Available

No

Study Details

Full Title

Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry

Principal Investigator

Joseph
Salama

Protocol Number

PRO00103137

NCT ID

NCT04085029

Phase

N/A

Enrollment Status

Open to Enrollment